Knight Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Knight Capital Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$914K	Buy	+10,796	New	+$899K	0.02%	1108

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Knight Capital Group's TMO Position: Q2 2013 in Review

Knight Capital Group opened a new position in Thermo Fisher Scientific (TMO) in Q2 2013: 10,796 shares worth $914K. The stake represents 0.02% of the portfolio and ranks #1108 among its holdings.

802 funds tracked by Wall St. Rank hold TMO as of Q2 2013.

Knight Capital Group held 10,796 shares of Thermo Fisher Scientific worth $914K as of Q2 2013.
Thermo Fisher Scientific was a new Knight Capital Group position in Q2 2013.
Thermo Fisher Scientific made up 0.02% of Knight Capital Group's portfolio in Q2 2013, its #1108 holding.
802 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.